A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive.Laila I. Muderspach, Jeffrey S. Weber, Sharon P. Wilczynski et al.|PubMed|2000Cited by 311
A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasiaLynda D. Roman, Jeffrey S. Weber, Sharon P. Wilczynski et al.|Gynecologic Oncology|2007Cited by 117
Therapeutic Vaccination for HPV Induced Cervical CancersJoeli Brinkman, W. Martin Kast, Pamela Stone et al.|Disease Markers|2007Cited by 47
The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management.Joeli Brinkman, W. Martin Kast, Angela S. Caffrey et al.|PubMed|2005Cited by 36
Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:CW. Martin Kast, Andrew W. Woodham, Joseph G. Skeate et al.|Clinical Immunology|2015Cited by 24